Cephalosporin-Related Neurotoxicity in a Ceftriaxone-Treated Critically Ill Child: A Case Report

• Published in: Case reports in acute medicine Vol. 6; no. 1; pp. 19 - 24
• Main Authors: Sylva, Marc, Abdulla, Alan, Koch, Birgit C.P., Mulder, Jaap
• Format: Journal Article
• Language: English
• Published: Basel, Switzerland Karger Publishers 19.12.2023
• Subjects: Case Report; ceftriaxone; child; encephalopathy; therapeutic drug monitoring; Therapeutic drug monitoring; Ceftriaxone; Child; Encephalopathy
• ISSN: 2504-5288; 2504-5288
• DOI: 10.1159/000534890

Abstract Introduction: We describe a child with meningococcal sepsis who suffered cephalosporin-related neurotoxicity. Case Presentation: A four-year-old girl was treated with intravenous ceftriaxone and supportive therapy. After rapid improvement, inotropic and respiratory support was stopped within 2 days. However, she developed renal failure and, on day four, deteriorated neurologically. Research into the cause of her encephalopathy revealed supra-therapeutic ceftriaxone concentrations with greatly increased unbound fractions leading to the diagnosis of cephalosporin-related neurotoxicity. Ceftriaxone treatment was discontinued, and renal replacement therapy was initiated on day six. With both discontinuation of ceftriaxone and renal replacement therapy, the girl’s condition improved rapidly. Conclusion: We postulate that in the described case both renal impairment and hypoalbuminemia played an important role in the development of high unbound ceftriaxone serum levels. We advocate therapeutic drug monitoring for ceftriaxone in critically ill children with renal failure or hypoalbuminemia.